Cullen Enhanced Equity Income C holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Cullen Enhanced Equity Income Fund Class C ENHCX
- NAV / 1-Day Return 10.70 / −0.19 %
- Total Assets 144.3M
-
Adj. Expense Ratio
1.750%
- Expense Ratio 1.750%
- Distribution Fee Level Below Average
- Share Class Type Level Load
- Category Derivative Income
- Investment Style Large Value
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 4.33%
- Turnover 127%
USD | NAV as of Oct 02, 2026 | 1-Day Return as of Oct 02, 2026, 12:55 AM GMT+0
Morningstar’s Analysis ENHCX
Will ENHCX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 35.6
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
International Business Machines Corp | 4.04 | 6M | Technology |
ConocoPhillips | 3.86 | 6M | Energy |
Merck & Co Inc | 3.76 | 5M | Healthcare |
Sysco Corp | 3.69 | 5M | Consumer Defensive |
Bristol-Myers Squibb Co | 3.64 | 5M | Healthcare |
UnitedHealth Group Inc | 3.41 | 5M | Healthcare |
Bbh Money Market Sweep | 3.41 | 5M | Cash and Equivalents |
VICI Properties Inc Ordinary Shares | 3.40 | 5M | Real Estate |
Duke Energy Corp | 3.29 | 5M | Utilities |
Truist Financial Corp | 3.24 | 5M | Financial Services |